Recent Advances in Surveillance Colonoscopy for Dysplasia in Inflammatory Bowel Disease

Overview

Journal Clin Endosc

Date 2022 Nov 18

PMID 36397275

Authors

Soo-Young Na

Won Moon

Affiliations

Soon will be listed here.

Abstract

Inflammatory bowel disease (IBD) has a global presence with rapidly increasing incidence and prevalence. Patients with IBD including those with ulcerative colitis and Crohn's disease have a higher risk of developing colorectal cancer (CRC) compared to the general population. Risk factors for CRC in patients with IBD include long disease duration, extensive colitis, primary sclerosing cholangitis, family history of CRC, stricture, and prior dysplasia. Surveillance colonoscopy for CRC in patients with IBD should be tailored to individualized risk factors and requires careful monitoring every year to every five years. The current surveillance techniques are based on several guidelines. Chromoendoscopy with targeted biopsy is being recommended increasingly, and high-definition colonoscopy is gradually replacing standard-definition colonoscopy. However, it remains unclear whether chromoendoscopy, virtual chromoendoscopy, or white-light endoscopy has better efficiency when a high-definition scope is used. With the development of new endoscopic instruments and techniques, the paradigm of surveillance strategy has gradually changed. In this review, we discuss cutting-edge surveillance colonoscopy in patients with IBD including a review of literature.

Citing Articles

Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance.

Fasulo E, DAmico F, Zilli A, Furfaro F, Cicerone C, Parigi T Cancers (Basel). 2025; 17(1.

PMID: 39796690 PMC: 11718813. DOI: 10.3390/cancers17010060.

Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases?.

Petito V, Di Vincenzo F, Putignani L, Abreu M, Regenberg B, Gasbarrini A Genes (Basel). 2024; 15(4).

PMID: 38674347 PMC: 11049804. DOI: 10.3390/genes15040414.

Potential Oral Microbial Markers for Differential Diagnosis of Crohn's Disease and Ulcerative Colitis Using Machine Learning Models.

Kang S, Kim H, Kim S, Kim J, Park S, Lee C Microorganisms. 2023; 11(7).

PMID: 37512838 PMC: 10385744. DOI: 10.3390/microorganisms11071665.

A Review of Colonoscopy in Intestinal Diseases.

Hong S, Baek D Diagnostics (Basel). 2023; 13(7).

PMID: 37046479 PMC: 10093393. DOI: 10.3390/diagnostics13071262.

References

Olen O, Erichsen R, Sachs M, Pedersen L, Halfvarson J, Askling J . Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020; 395(10218):123-131. DOI: 10.1016/S0140-6736(19)32545-0. View

Eaden J, Abrams K, Mayberry J . The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48(4):526-35. PMC: 1728259. DOI: 10.1136/gut.48.4.526. View

Buchner A, Shahid M, Heckman M, McNeil R, Cleveland P, Gill K . High-definition colonoscopy detects colorectal polyps at a higher rate than standard white-light colonoscopy. Clin Gastroenterol Hepatol. 2009; 8(4):364-70. DOI: 10.1016/j.cgh.2009.11.009. View

Gulati S, Dubois P, Carter B, Cornelius V, Martyn M, Emmanuel A . A Randomized Crossover Trial of Conventional vs Virtual Chromoendoscopy for Colitis Surveillance: Dysplasia Detection, Feasibility, and Patient Acceptability (CONVINCE). Inflamm Bowel Dis. 2018; 25(6):1096-1106. DOI: 10.1093/ibd/izy360. View

Kandiah K, Subramaniam S, Thayalasekaran S, Chedgy F, Longcroft-Wheaton G, Fogg C . Multicentre randomised controlled trial on virtual chromoendoscopy in the detection of neoplasia during colitis surveillance high-definition colonoscopy (the VIRTUOSO trial). Gut. 2020; 70(9):1684-1690. PMC: 8355878. DOI: 10.1136/gutjnl-2020-320980. View

Feuerstein J, Rakowsky S, Sattler L, Yadav A, Foromera J, Grossberg L . Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. Gastrointest Endosc. 2019; 90(2):186-195.e1. DOI: 10.1016/j.gie.2019.04.219. View

Kiesslich R . SCENIC update 2021: Is chromoendoscopy still standard of care for inflammatory bowel disease surveillance?. Gastrointest Endosc. 2021; 95(1):38-41. DOI: 10.1016/j.gie.2021.10.009. View

Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H . Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. Gastroenterology. 2016; 151(6):1122-1130. DOI: 10.1053/j.gastro.2016.08.002. View

Subramanian V, Ramappa V, Telakis E, Mannath J, Jawhari A, Hawkey C . Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis. 2012; 19(2):350-5. DOI: 10.1002/ibd.23002. View

10.

Bisschops R, Bessissow T, Joseph J, Baert F, Ferrante M, Ballet V . Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial. Gut. 2017; 67(6):1087-1094. DOI: 10.1136/gutjnl-2016-313213. View

11.

Soetikno R, Subramanian V, Kaltenbach T, Rouse R, Sanduleanu S, Suzuki N . The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology. 2013; 144(7):1349-52, 1352.e1-6. DOI: 10.1053/j.gastro.2013.04.008. View

12.

Beaugerie L, Svrcek M, Seksik P, Bouvier A, Simon T, Allez M . Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013; 145(1):166-175.e8. DOI: 10.1053/j.gastro.2013.03.044. View

13.

Lutgens M, van Oijen M, van der Heijden G, Vleggaar F, Siersema P, Oldenburg B . Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013; 19(4):789-99. DOI: 10.1097/MIB.0b013e31828029c0. View

14.

Murthy S, Feuerstein J, Nguyen G, Velayos F . AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology. 2021; 161(3):1043-1051.e4. DOI: 10.1053/j.gastro.2021.05.063. View

15.

GOLDGRABER M, Kirsner J . CARCINOMA OF THE COLON IN ULCERATIVE COLITIS. Cancer. 1964; 17:657-65. DOI: 10.1002/1097-0142(196405)17:5<657::aid-cncr2820170515>3.0.co;2-7. View

16.

Wei S, Shieh M, Chang M, Chang Y, Wang C, Wong J . Long-term follow-up of ulcerative colitis in Taiwan. J Chin Med Assoc. 2012; 75(4):151-5. DOI: 10.1016/j.jcma.2012.02.017. View

17.

Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R . Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009; 136(5):1561-7. DOI: 10.1053/j.gastro.2009.01.064. View

18.

Kiesslich R, Fritsch J, Holtmann M, Koehler H, Stolte M, Kanzler S . Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003; 124(4):880-8. DOI: 10.1053/gast.2003.50146. View

19.

Pellise M, Lopez-Ceron M, Rodriguez de Miguel C, Jimeno M, Zabalza M, Ricart E . Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc. 2011; 74(4):840-8. DOI: 10.1016/j.gie.2011.05.013. View

20.

Winther K, Jess T, Langholz E, Munkholm P, Binder V . Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004; 2(12):1088-95. DOI: 10.1016/s1542-3565(04)00543-9. View